Johnson & Johnson Vision Appointment

Johnson & Johnson Vision Appointment
Colin Kerr
Colin Kerr
Published: Friday, December 13, 2019
Warren Foust
Johnson & Johnson Vision has announced that Warren Foust will assume the role of Worldwide President, Surgical for Johnson & Johnson Vision, effective December 2, 2019. He replaces Tom Frinzi, who will retire at the end of 2019. Mr Foust has two decades of global healthcare industry experience, and specific expertise in surgical medical devices. Most recently, he served as Worldwide President of Mentor and was a member of the Cardiovascular and Specialty Services (CSS) Leadership Team within Johnson & Johnson. “When thinking about who would be the next leader of the surgical vision business, I knew we needed a leader with a track record of success in leading global healthcare businesses, a people-centered leadership style, a keen appreciation for the customer experience, and a high touch approach to seeking customer partnership and input,” said Tom Frinzi, outgoing Worldwide President, Surgical, Johnson & Johnson Vision. “Warren Foust exemplifies all of these traits, he’s a beloved leader at Johnson & Johnson, and this organization is in great hands with Warren at the helm.” Mr Foust said he will be visiting every region in his first 100 days on the job, connecting directly with the ophthalmology community at industry events, customer meetings and Johnson & Johnson Vision’s annual kick-off meetings across APAC, EMEA and North and South America. “I’ll be making every effort to reach out – to immerse myself in the industry, develop a deep understanding of unmet clinical needs and unmet patient needs, and form foundational relationships with the surgeons driving this industry forward. I’m excited to get started, and thankful to be part of the legacy Tom leaves to this company, team and industry,” said Mr Foust.
Tags: Johnson & Johnson Vision
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...